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Background: Impairments of memory are commonly reported by people with traumatic brain injuries (TBI). Such
deficits are persistent, debilitating, and can severely impact quality of life. Currently, many do not routinely receive
follow-up appointments for residual memory problems following discharge.
Methods/Design: This is a multi-centre, randomised controlled trial investigating the clinical and cost-effectiveness
of a group-based memory rehabilitation programme. Three hundred and twelve people with a traumatic brain
injury will be randomised from four centres. Participants will be eligible if they had a traumatic brain injury more
than 3 months prior to recruitment, have memory problems, are 18 to 69 years of age, are able to travel to one of
our centres and attend group sessions, and are able to give informed consent. Participants will be randomised in
clusters of 4 to 6 to the group rehabilitation intervention or to usual care. Intervention groups will receive 10 weekly
sessions of a manualised memory rehabilitation programme, which has been developed in previous pilot studies.
The intervention will include restitution strategies to retrain impaired memory functions and compensation strategies to
enable participants to cope with their memory problems. All participants will receive a follow-up postal questionnaire
and an assessment by a research assistant at 6 and 12 months post-randomisation. The primary outcome is the Everyday
Memory Questionnaire at 6 months. Secondary outcomes include the Rivermead Behavioural Memory Test-3, General
Health Questionnaire-30, health related quality of life, cost-effectiveness analysis determined by the EQ-5D and a service
use questionnaire, individual goal attainment, European Brain Injury Questionnaire (patient and relative versions), and the
Everyday Memory Questionnaire-relative version. The primary analysis will be based on intention to treat. A mixed-model
regression analysis of the Everyday Memory Questionnaire at 6 months will be used to estimate the effect of the group
memory rehabilitation programme.
Discussion: The study will hopefully provide robust evidence regarding the clinical and cost-effectiveness of a
group-based memory rehabilitation intervention for civilians and military personnel following TBI. We discuss our
decision-making regarding choice of outcome measures and control group, and the unique challenges to recruiting
people with memory problems to trials.
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Impairments of memory are the most common cognitive
deficits reported by people with traumatic brain injuries
(TBIs), affecting 40 to 60% of patients [1,2]. These mem-
ory problems are not only persistent, but are debilitating
and difficult to treat [3]. Memory deficits may also affect
the extent to which patients engage with other interven-
tions and rehabilitation. The safety of such patients can
also be compromised, making them vulnerable citizens
in the home (for example, forgetting to turn the stove off),
community (for example, forgetting road rules), and work
(for example, forgetting important documents) settings.
Memory problems consequently have a devastating effect
on the psychological wellbeing of the individuals and
others around them [4].
Costs of morbidity due to TBI are incurred by the
healthcare system and those outside it (in terms of loss
of productivity due to short-term sick leave and early
retirement), and through non-medical costs (for example,
transformations of house or work environments, etc.). In
addition, informal care by family or friends can dominate
the costs of care for affected individuals. For TBI, the dir-
ect medical costs and indirect costs were estimated at $60
billion in the United States in 2000 [5]. The full costs of
dealing with memory problems caused by TBI in the UK
are not known. Care costs escalate when an intervention
is provided on an inpatient basis, but Salazar et al. [6]
demonstrated that the benefits of inpatient and home
cognitive rehabilitation programmes for TBI, in terms of
return to duty (for military personnel) or employment,
were similar.
Cognitive rehabilitation is a structured set of thera-
peutic activities designed to retrain an individual’s mem-
ory and other cognitive functions. A narrative review [7]
found cognitive rehabilitation to be beneficial for treat-
ing cognitive deficits following brain damage. There are
recommendations for the provision of cognitive rehabi-
litation for people with acquired brain injuries (for
example, European Federation of Neurological Societies
Guidelines on cognitive rehabilitation [8]; National Service
Framework for Long term Conditions [9]). However,
recommendations are always qualified by statements
that highlight the need for more research, to support
the recommendations.
Some randomised controlled trials (RCTs) have dem-
onstrated the effectiveness of cognitive rehabilitation
following brain injuries. These have mainly focussed on
attention, executive functions, and visual neglect, but
memory rehabilitation has not been sufficiently researched
[10]. Most evidence for memory rehabilitation comes
from single-case experimental design studies and con-
trolled clinical trials. The few RCTs and quasi-RCTs in
this area have offered some support for the effectiveness
of intervention. Wilson et al. [11] examined an externalmemory aid, Neuropage. This enabled participants to
achieve more memory-related goals than when it was not
available. Doornhein and de Haan [12] reported that
patients who received a memory training programme
performed significantly better than those in a pseudo-
treatment control group on trained memory tasks, but
no differences were observed on subjective ratings of
everyday memory functions. Kaschel et al. [13] reported
that imagery mnemonics significantly improved delayed
recall of verbal material and reduced observer-rated re-
ports of memory failures. However, systematic reviews
on memory rehabilitation have not found evidence to
support or refute the effectiveness of such programmes
[14,15]. This lack of evidence is partly due to the paucity
of well-designed trials and has led a recent meta-analysis
to conclude that ‘the results for memory rehabilitation are
mixed and weak’ [10] (p.33). These authors suggested that
‘researchers need to reduce reliance on single-subject and
single group designs’ (p.34) and recommended more RCT
evidence, a view supported by others [16]. At a sympo-
sium on disorders of memory, Wilson called for ‘better
evaluation of memory rehabilitation programmes’ [17]
(p.e4-5). This is a conclusion that our systematic reviews
of memory rehabilitation following TBI [10], stroke [18],
multiple sclerosis [19] have also reached. A small scale
RCT (n = 72) was conducted to evaluate a group memory
rehabilitation programme [20]. Patients with memory
problems were randomly allocated to one of three group
treatment programmes: compensation strategy training,
restitution, or a self-help attention placebo control. The
results showed that there were no statistically significant
differences in outcome. However, the trend in the results
and the qualitatively analysed participant feedback inter-
views [21] indicated the interventions seemed worthy of
further evaluation. These studies provided feasibility and
pilot data for the present study.
Currently, TBI patients with memory problems do not
routinely receive follow-up rehabilitation after the early
intensive phase, even though their abilities and needs
may change once discharged from clinical services. This
is mainly due to the current lack of evidence of clinical
and cost-effectiveness of the intervention, and resource
limitations. This study seeks to address these concerns.
Methods/Design
Trial objectives
The primary objective is to determine whether attending
a group memory rehabilitation programme is associated
with subjective reports of improved management of mem-
ory in daily life when compared to a usual care (UC) con-
trol. The secondary objectives are to assess whether the
intervention is associated with improvements in ‘object-
ively’ assessed memory abilities, participants’ ability to
achieve individually set goals, health-related quality of life,
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the cost-effectiveness of the intervention will also be
investigated.Trial design
This is a multi-centre, parallel group, randomised con-
trolled trial (RCT).Site and participant recruitment
The study will be conducted in at least four centres in
the UK. New centres will be activated as old ones shut
down due to their participant pools being exhausted.
Participants are identified through NHS hospitals, re-
habilitation centres and charities (for example, military
or head injury charities). A letter will be sent to individuals
who are identified as potential participants by a member
of the clinical team; this letter will include a patient infor-
mation sheet, a consent form and a paid reply envelope. If
the potential participant is interested in taking part, he or
she is requested to complete the slip and return it in the
envelope directly to the Assistant Psychologist (AP). Self-
referral will also be possible via public-facing information
on the study website, newsletters and posters. Participants
recruited via this route will be made aware that their GP
may be contacted to confirm the TBI diagnosis. Recruit-
ment is planned to cover a 25-month period.Informed consent
Written informed consent will be obtained by the AP.
We will explain to participants that their participation is
entirely voluntary and they are free to withdraw at any
time; in the event of their withdrawal, any data collected
up until that point would be kept by the research team.
Participants will also be asked to allow the research team
to have access to their clinical notes to obtain infor-
mation on their clinical diagnosis, severity of injury
(Glasgow Coma Scale score), time since injury, and
other medical conditions. They will be asked whether
they consent to a follow-up interview to assess treatment
acceptability and will be informed that if allocated to the
intervention group, sessions may be video-taped to ensure
treatment fidelity. The GPs of consenting participants will
be sent a letter to inform them of their patients’ involve-
ment in the trial.Inclusion criteria
Patients are eligible for the trial if they i) were admitted
to hospital with a TBI more than 3 months prior to re-
cruitment, ii) report having memory problems as assessed
at baseline, iii) are 18 to 69 years of age, iv) are able to
travel to one of the study centres and attend group ses-
sions, and v) give informed consent.Exclusion criteria
Potential participants will be excluded if they i) are
unable or unsuitable to engage in group treatment if
allocated, ii) are involved in other psychological inter-
vention studies, or iii) have impairment of language, as
assessed at baseline.
Initial screening assessment
At the first appointment, the AP will explain the study
and make clear that the initial screening assessments are
required to check that the patient meets the inclusion
criteria. The AP will obtain informed consent and con-
duct the initial assessments. The following assessments
will be conducted at screening:
1. The Everyday Memory Questionnaire-patient
version (EMQ-p [22]; a subjective measure of the
frequency of memory failures in daily life. We will
be using a modified version of the EMQ, which has
two sections: (i) frequency of forgetting of individual
items and (ii) importance of each individual item to
the patient.
2. The Rivermead Behavioural Memory Test-3rd
edition (RBMT-3; [23]) an ecologically valid measure
of memory ability. The RBMT-3 has been used in
previous studies and is the version currently used
clinically.
3. The Sheffield Screening Test for Acquired Language
Disorders (SST; [24]) used to assess language ability.
We will use a cut-off score <17 to determine
eligibility.
4. Premorbid level of intellectual functioning will be
estimated using the National Adult Reading Test
(NART; [25]).
5. General Health Questionnaire (GHQ-30; [26]) a
measure of mood.
Potential participants will be eligible to take part if they
meet the following requirements:
1. score 24 or more on Section 1 (frequency) of the
EMQ OR.
2. score below the 25th percentile on the RBMT-3.
Those who do not meet the inclusion criteria
will be notified by letter to thank them for their
interest in the study and a brief report of their
test results will be provided if requested. Those
who meet the inclusion criteria will be phoned to
arrange a second assessment session if they
are willing to continue. We will also check
whether they can nominate a relative or friend
who knows them well who would be willing
to complete two questionnaires about the
participant’s memory.
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The purpose of this assessment, conducted 2 weeks
(+/- 1 week) after the first assessment, is to achieve the
following:
1. set the short- and long-term goals that individual
participants would like to achieve by the end of the
study (all participants set one short term and long
term goal up to a maximum of five).
2. complete the EQ5D (a health-related quality of life
measure [26]).
3. complete the service-use questionnaire.
4. check their availability in the event they are assigned
to the intervention group.
5. collect the EMQ-r, completed by the carer/relative.Participant outcome assessments
Outcome assessments will occur at 6 and 12 months
after randomisation. The NHS number will be supplied
to the Medical Research Information Service to allow a
mortality check prior to follow-up.
The primary outcome measure will be the EMQ-
patient version [22]. The study will use the frequency
component as the primary outcome measure and the
importance component will be used to develop a scoring
mechanism to develop an assessment, which takes fre-
quency and importance into account.
Participants will receive a questionnaire pack by post,
and will be requested to return this to the Nottingham
Clinical Trials Unit (NCTU) as soon as possible; how-
ever, participants do have the option of requesting help
in completing these questionnaires if necessary. If ques-
tionnaires have missing items or are not returned,
participants will be telephoned to obtain the missing
information. The questionnaire pack will consist of: the
modified EMQ (patient and relative version), GHQ-30,
European Brain Injury Questionnaire [27] (patient and
relative versions), EQ5D [28], and a bespoke service-use
questionnaire. A research assistant, who is unaware of
the group allocation, will conduct the RBMT-3 and as-
sess goal attainment.Minimisation of bias
The participants and APs will not be blind to the allo-
cated treatment. The primary outcome is participant
completed and sent back directly to the data entry team.
The RBMT and assessment of goal attainment (secondary
outcomes) will be conducted by the RA in person. To pre-
vent unblinding, the RA will request participants not to
discuss any aspect of being involved with the study. The
RA will also be required to guess the treatment allocation
for each participant and this will be compared later to the
actual allocation, to determine the degree of unblinding.Randomisation
Participants will be randomised in clusters of four to six.
Once four to six participants have been identified and
consented, they will be randomly allocated, as a group,
to intervention or usual care (UC) (1:1 ratio). The ran-
domisation will be based on a computer generated
pseudo-random code using random permuted blocks of
randomly varying size, created by the NCTU in accord-
ance with their standard operating procedure and held
on a secure server. The randomisation will be stratified
by study site. Access to the sequence will be confined to
the NCTU IT Manager. Investigators will access the
allocation for each group by means of a remote, internet-
based randomisation system developed and maintained by
the NCTU. The sequence of treatment allocations will be
concealed from the study statistician until all interventions
have all been assigned and recruitment, data collection,
and all other study-related assessments are complete.
Duration of participant participation
Figure 1 shows the expected progress of the study. Par-
ticipants are in the study for approximately 13 months
from the initial screening assessment (12 months from
randomisation). Participants will leave the study when
they have completed the 12-month follow-up.
Group-based memory intervention
Each group led by an AP will consist of 4 to 6 partic-
ipants. Participants will receive 10 group memory-
rehabilitation sessions (1.5 hours long, once a week
for 10 weeks), following a treatment manual, which
was developed and tested in the previous study (a de-
scription of the manual has been published [14,20]).
The original manual has been revised following extensive
consultation and feedback from participants. Qualitative
research [22] also found that the group format, compos-
ition, and duration were acceptable to participants, and
delivery of the intervention was feasible. The intervention
will include restitution strategies to retrain memory func-
tions, including attention retraining and strategies to im-
prove encoding and retrieval. Compensation strategies
will be taught, including internal mnemonics (such as
chunking, use of first letter cues, rhymes), use of external
devices (such as diaries, mobile phones, calendars), and
ways of coping with memory problems. The importance
of ‘errorless learning’ [29] will also be taught.
Control group (usual care)
Participants will receive their usual clinical care. The
majority of participants will no longer be receiving any
formal rehabilitation. They may be attending self-help
groups or services from charities supporting people with
head injuries, for example, Headway.
Figure 1 CONSORT diagram.
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both groups. This may include referral to employment
rehabilitation services, self-help groups or support from
specialist charities, such as Headway. Any additional in-
put (including psychological or medical interventions)
participants receive during the study will be noted from
the service use questionnaire.Compliance with interventions
The assistant psychologist records whether participants
attend each of the treatment sessions and the reasons if
sessions are not attended. To ensure the fidelity of the
intervention, the content of treatment will be described
and analysed. This will be achieved by video recording
20 intervention sessions. Sessions will be purposively
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from the start, middle and end of the ten-week course
and recordings will be made across the intervention
period. Practices for video-recording will draw upon
guidance on minimizing intrusiveness of the recording
[30,31]. Methods used in previous work will be drawn
on to analyse the content of training within rehabilita-
tion contexts [32,33]. Two independent assessors will
separately analyse the video recordings using a custom-
ized score sheet to capture a variety of key elements
spanning all aspects of the intervention. Assessors will
code these factors as present or absent over a series of
time intervals. This method has previously been used in
the pilot study and was able to determine treatment
fidelity without disrupting the group sessions [34].
Sample size and justification
The sample size calculation is based on the primary
outcome measure (EMQ-p frequency total score) at six
months post-randomisation. The main study aim is to
detect a minimum clinically relevant difference in mean
EMQ-p frequency total score of 12 between the memory
intervention group and the usual care group. A 12-point
difference on this measure was deemed to be a clinically
significant change based on our pilot data [20] and clin-
ical interviews. A common standard deviation of 21.9
from the pilot gives an effect size of 0.55. A type 1 error
of 0.05 and power of 90% were used for the calculation.
A fixed effects model at the level of the four centres is
assumed, with 10% of the total variation due to between-
centre variation. The participants are cluster randomised
into groups of 6 at the second level and a random effects
model will be used with a small intracluster correlation
coefficient assumed (ICC = 0.1). This ICC is likely to be
small because within each centre the therapist, interven-
tion, and delivery location do not vary. Using the ‘Optimal
Design’ software with these parameters, the calculation
gives 10 groups per centre. Data from the pilot study and
taking account that the control group only receives usual
care suggests a possible dropout rate of 20%, so 26 groups
of each intervention will be required or 312 participants
in total. Based on our pilot study, we estimate we will need
to screen 400 participants to recruit the required 312.
Clinicians at the four centres have indicated that this is an
achievable target in the timeframe proposed.
Statistical analysis
Database lock will take place once all data entries have
been checked and sufficient verification processes have
been completed. Analyses will be completed with Stata
version 11.2 or above. The psychometric properties of
the instruments used will be evaluated when sufficient
baseline data have been collected. The baseline charac-
teristics will be described using appropriate summarystatistics to examine balance between the two rando-
mised groups.
The primary analysis will use a multi-level linear
model with baseline EMQ score as a covariate, centre as
a fixed effect and random effects, which take appropriate
account of clustering according to allocated group [35,36].
The between group comparison will be presented as the
difference in mean EMQ-p score at 6 months between the
two groups with a 95% confidence interval [35,36]. Partici-
pants will be analysed as randomised (Intention to Treat)
regardless of adherence with allocation. It is planned that
the primary analysis will be based on participants with
available data with no imputation for participants with
missing outcomes. The distributions of raw outcome
scores and residuals will be examined and the data suit-
ably transformed or a non-parametric analysis employed if
necessary.
Supportive analyses for the primary outcome will include
imputation of missing data exploring different scenarios
for the missing data, accounting for non-compliance with
the group memory rehabilitation programme and adjusting
for any characteristics assessed at baseline with an obser-
ved imbalance between the two groups.
All secondary variables will be presented using appro-
priate descriptive statistics and analysed with appropriate
regression models using the same techniques as for the
primary outcome. Differences between the two groups
will be presented with 95% confidence intervals. All sec-
ondary analyses will be interpreted with caution as the
sample size calculation is based on the primary outcome.
The analyses for all the outcomes will be repeated with
the 12 month follow-up data following similar distribu-
tion checks.
Full details of all statistical analyses will be given in a
statistical analysis plan, which will be finalised prior to
database lock.
Health economic evaluation
The cost-effectiveness will be assessed from the perspec-
tive of the UK NHS and personal social services. The
costs associated with the intervention will be determined
by calculating the cost of staff time, materials, etc. used
in providing the intervention. These will be compared
with changes in the number of visits to GPs, hospital,
prescribed medication, and social services contacts in
the intervention and control groups during the investi-
gation. The costs will be compared with the outcomes
generated and a series of incremental cost-effectiveness
ratios computed, including a cost/Quality Adjusted Life
Year (QALY) analysis - based on changes in EQ-5D. A
series of one-way sensitivity analyses will be undertaken
to determine the extent to which baseline findings will
change in light of parameter variation. Given the limited
time duration of the study and follow-up, a decision
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effectiveness of the intervention from a lifetime perspec-
tive, a series of scenarios will be constructed to reflect the
extent to which differential outcomes can be predicted to
continue over longer time periods, using expert opinion
and information available in the literature. A probabilistic
sensitivity analysis will be carried out to determine the
extent to which the intervention can be regarded as repre-
senting value for money.
Assessment of safety and adverse events
The adverse event risks of taking part in the study have
been assessed. A part of the baseline assessment is to as-
sess the memory of the participants such that they may
become aware of memory problems that they did not
know that they had. As a result, the main risk associated
with this intervention is distress caused by the reali-
sation that their memory is not as good as they had
thought. However, first, distress caused in this way is
considered very unlikely; and, second, any distress caused
is likely to be mild. In addition, for the intervention group,
this is also dealt with during the course of the intervention
and the group therapy will address this on a participant by
participant basis. So overall the risk has been assessed as
negligible.
Participants who withdraw
No withdrawal criteria have been specified, and partici-
pants have the right to withdraw from the study at any
time. The reasons for leaving the study will be recorded,
but participants are not obliged to give reasons. Partici-
pants will be assured that withdrawal will not affect the
care they receive. They will be informed at the start of
the study that data collected up to the point of with-
drawal will be retained and may be used in the final ana-
lysis. There will be no replacement of participants who
withdraw.
All reasonable attempts will be made to contact any
participant lost to follow-up during the course of the
study in order to complete assessments.
Feedback interviews
A feedback interview will be conducted within 2 months
of the 6 month appointments, with 32 purposefully se-
lected and willing participants: 16 from each group. This
will be 4 intervention and 4 control participants, from
each participating centre. The selection strategy will be
designed to include participants with varying levels of
memory impairments, and with varying social situations.
The interviews will be conducted by a second RA (RA2)
who was not involved with the participant’s assessment
or treatment, thereby reducing social desirability response
bias. The RA2 will become aware of the group alloca-
tions during the interview so will not be blind to theintervention. The interview will be audio recorded
using a digital recorder, transcribed, and analysed using a
thematic analysis (following the protocol prescribed by
Braun and Clarke [37]). Participant consent for the inter-
views will be sought separately. The interviews will pro-
vide important feedback on participants’ perception of
progress over time and for those in the intervention
groups, the quality of the interventions provided, and as
such will serve as a process measure. Insights from this
qualitative data and analysis will serve to inform develop-
ments of the intervention programme in the future and to
generate user-oriented proposals about areas for further
investigations. For those in the control group the inter-
views will provide confirmation of the nature of usual care
received.
Criteria for terminating the study
The study maybe stopped as a whole because of a
change in opinion of the Research Ethics Committee
(REC) or safety concerns or issues with study conduct at
the discretion of the sponsor.
Trial management
A Trial Management Group (TMG) will be convened
and meet regularly. This group will be in charge of the
everyday running of the trial. The Trial Steering Com-
mittee (TSC) will oversee the conduct of the study and
will have an independent Chair. A service user represen-
tative and a member from one of the military charities
will also be invited to join this group. It will advise on
recruitment strategies, monitor progress with recruitment,
and check adherence to the study protocol. Observers
from the National Institute for Health Research - Health
Technology Assessment (NIHR HTA) programme (the
funder) will be invited to TSC meetings. The Data Moni-
toring Committee (DMC) will be an independent group,
the members of which have no other involvement with
the study. Members of this committee will include reha-
bilitation professionals and an experienced study statisti-
cian. It will safeguard the interests of trial participants,
with particular reference to safety and the efficacy of the
intervention, monitor the overall progress and conduct of
the trial and assist and advise the Investigators so as to
protect the validity and credibility of the trial.
Service user involvement
Our service user representative has had experience of
rehabilitation in NHS services and has taken part in the
previous study. Their role will be to advise on recruit-
ment and dissemination options, and will contribute to
the development of the intervention manual and the lay
summary of the project. This service user will sit on the
TSC. Other service user representatives will be recruited
to the TSC and DMC from relevant charities (for example,
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volvement will contribute to: team meetings and project
management decisions, project approval through REC,
recruitment and consent (contribute to the develop-
ment of participant information sheets), data gathering
(through developing patient information leaflets explain-
ing the survey tools where appropriate), interpretation of
findings (through the development of recommendations
for practice and patient information leaflets about ther-
apy), and dissemination of the findings through existing
networks.
Definition of a protocol deviation
A protocol deviation is an unanticipated or unintentional
divergence or departure from the expected conduct of a
study inconsistent with the protocol, consent document
or other study procedures. All protocol deviations will
be recorded on the electronic case report form (eCRF) by
local investigator staff.
Ethical approval
Ethical approval was obtained from the NRES Committee
East Midlands - Nottingham 1 on 21.09.12. (ref: 12/EM/
0324).
Discussion
This study was conceptualised in response to a commis-
sioned call for ‘proposals concerning people needing
physical or psychological rehabilitation following trauma
in a military or civilian context’ from the Health Tech-
nology Assessment (HTA) Programme [38]. Based on
our pilot work [14] and feedback from participants [21],
we decided to combine restitution and compensation
approaches in the intervention. We also decided to have
a usual care control group, as having a self-help control
group was difficult to organise and facilitate.
Our choice of primary outcome measure was a point
of contention, with some of our reviewers suggesting
‘objective’ measures of memory, others recommending
the use of goal attainment scaling, and yet others agree-
ing that the primary outcome had to be a subjective re-
port of memory function in daily life. We have retained
both an objective measure of memory and a measure of
goal attainment, but these are secondary outcomes. Most
objective measures have poor ecological validity. Goal
attainment poses challenges in setting goals that can be
precisely measured and the changeable nature of some of
the goals, given that our outcomes are measured 6 and 12
months after the goals were set.
We anticipate that one of the biggest challenges to
recruit to this study will be potential participants’ mem-
ory problems themselves. Even those interested in taking
part in this trial when they receive our invitation letter
may forget to respond. To address this, we have soughtan amendment to our original ethics approval to include
a single phone call to follow-up non-responders to the
invitation letter to enquire whether they remember
receiving the letter and whether they would like to
participate.
Trial status
The first centre was open to recruitment on the 6 February
2013 and the first participant consented on 20 February
2013. At the time of preparing this manuscript, 166 people
have consented, and 85 have been randomised. Recruit-
ment is due to finish in March 2015.
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